Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The relationship of pregnancy to the use of highly active antiretroviral therapy

Article Abstract:

Pregnant women with HIV infection are less likely to be given highly active antiretroviral therapy than non-pregnant women. Highly active antiretroviral therapy is a combination of two or more drugs, whereas many pregnant women are only given zidovudine.

Author: Ahdieh, Linda, Minkoff, Howard, Greenblatt, Ruth M., Watts, Heather, Schmidt, Julie, Schneider, Michael, Stek, Alice
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
Pregnancy, HIV infection in pregnancy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the Women's Interagency HIV Study

Article Abstract:

Most HIV-infected women will not develop precancerous cervix abnormalities, according to a study of 1,639 HIV-infected women and 452 HIV-negative women. Only 6% of the HIV-infected women developed such changes.

Author: Ahdieh, Linda, Minkoff, Howard, Anastos, Kathryn, Melnick, Sandra, Greenblatt, Ruth M., Watts, Heather, Massad, L. Stewart, Benning, Lorie, Miotti, Paolo, Moxley, Michael, Muderspach, Laila I.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
Risk factors, HIV infection, Cervix dysplasia, Complications

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus

Article Abstract:

An attempt is made to determine the incidence and predictors of genital warts and vulvar intraepithelial neoplasia among women with the human immunodeficiency virus. The incidence of warts among women who are human immunodeficiency virus seronegative is 1.31 versus 5.01 per 00 person-years among women who are seropositive, whereas the incidence of vulvar intraepithelial neoplasia is 1.31 versus 4.67 per 100 person-years.

Author: Minkoff, Howard, Levine, Alexandra M., Watts, Heather, Sacks, Henry S., Palefsky, Joel M., Massad, L. Stewart, Moxley, Michael, Hessol, Nancy, Silverberg, Michael J., Springer, Gayle, Strickler, Howard D.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2004
Research and Development in the Physical, Engineering, and Life Sciences, Science & research, Research and Testing Services, Gynecological R&D, Research, Causes of, Complications and side effects, Condyloma acuminatum, Genital warts, HIV (Viruses), HIV, Antiviral agents, Gynecological research, Antiretroviral agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drug therapy, HIV infections
Similar abstracts:
  • Abstracts: Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals
  • Abstracts: Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. CD4 (super)+ T cells: the great escape
  • Abstracts: Fluorescence detection of cervical intraepithelial neoplasia for photodynamic therapy with the topical agents 5-aminolevulinic acid and benzoporphyrin-derivative monoacid ring
  • Abstracts: Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation
  • Abstracts: Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.